Targeting Right Ventricle in Pulmonary Hypertension Gilead

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study is looking to see if giving ranolazine to subjects on stable pulmonary hypertension therapies but with right ventricular dysfunction (RVEF \<45%) will improve their health by improving right ventricular (RV) function.
Epistemonikos ID: c4249d73553235cb69d86f0885d6493d8e78f54a
First added on: May 17, 2024